These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 25122578

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.
    Ntamatungiro AJ, Muri L, Glass TR, Erb S, Battegay M, Furrer H, Hatz C, Tanner M, Felger I, Klimkait T, Letang E, KIULARCO Study Group.
    J Antimicrob Chemother; 2017 Jul 01; 72(7):2069-2074. PubMed ID: 28387865
    [Abstract] [Full Text] [Related]

  • 3. High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.
    Fofana DB, Soulié C, Baldé A, Lambert-Niclot S, Sylla M, Ait-Arkoub Z, Diallo F, Sangaré B, Cissé M, Maïga IA, Fourati S, Koita O, Calvez V, Marcelin AG, Maïga AI.
    J Antimicrob Chemother; 2014 Sep 01; 69(9):2531-5. PubMed ID: 24855120
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China.
    Wang J, Wang Z, Liu J, Yue Y, Yang S, Huang H, He C, Liao L, Xing H, Ruan Y, Shao Y.
    Sci Rep; 2015 Oct 08; 5():14823. PubMed ID: 26445885
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.
    Cabrera C, Cozzi-Lepri A, Phillips AN, Loveday C, Kirk O, Ait-Khaled M, Reiss P, Kjaer J, Ledergerber B, Lundgren JD, Clotet B, Ruiz L, EuroSIDA Study Group.
    Antivir Ther; 2004 Oct 08; 9(5):787-800. PubMed ID: 15535417
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Virological responses to atazanavir-ritonavir-based regimens: resistance-substitutions score and pharmacokinetic parameters (Reyaphar study).
    Pellegrin I, Breilh D, Ragnaud JM, Boucher S, Neau D, Fleury H, Schrive MH, Saux MC, Pellegrin JL, Lazaro E, Vray M.
    Antivir Ther; 2006 Oct 08; 11(4):421-9. PubMed ID: 16856615
    [Abstract] [Full Text] [Related]

  • 12. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.
    Silveira MP, Silveira CP, Guttier MC, Page K, Moreira LB.
    J Clin Pharm Ther; 2016 Dec 08; 41(6):689-694. PubMed ID: 27676134
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P, Ungsedhapand C, Ruxrungtham K, Boyd MA, Phanuphak P, Cooper DA, Law MG.
    HIV Med; 2007 Jan 08; 8(1):46-54. PubMed ID: 17305932
    [Abstract] [Full Text] [Related]

  • 15. Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients.
    Barth RE, Aitken SC, Tempelman H, Geelen SP, van Bussel EM, Hoepelman AI, Schuurman R, Wensing AM.
    Antivir Ther; 2012 Jan 08; 17(2):377-86. PubMed ID: 22297391
    [Abstract] [Full Text] [Related]

  • 16. Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients.
    Clevenbergh P, Boulmé R, Kirstetter M, Dellamonica P.
    HIV Med; 2004 Jul 08; 5(4):284-8. PubMed ID: 15236618
    [Abstract] [Full Text] [Related]

  • 17. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
    Zoufaly A, Jochum J, Hammerl R, Nassimi N, Raymond Y, Burchard GD, Schmiedel S, Drexler JF, Campbell NK, Taka N, Awasom C, Metzner KJ, van Lunzen J, Feldt T.
    J Antimicrob Chemother; 2015 Mar 08; 70(3):922-5. PubMed ID: 25428920
    [Abstract] [Full Text] [Related]

  • 18. Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01_AE-infected cohort.
    Zolfo M, Schapiro JM, Phan V, Koole O, Thai S, Vekemans M, Fransen K, Lynen L.
    AIDS Res Hum Retroviruses; 2011 Jul 08; 27(7):727-35. PubMed ID: 20854169
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.